Emulex Corp. (ELX) Tops Q1 EPS by 2c, Posts Strong Q2 Guidance
Tweet
Share
E-mailGet Alerts ELX Hot Sheet
Price: $7.99 --0%
Financial Fact:
General and administrative: 11.51M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
General and administrative: 11.51M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Emulex Corp. (NYSE: ELX) reported Q1 EPS of $0.13, $0.02 better than the analyst estimate of $0.11. Revenue for the quarter came in at $118.4 million versus the consensus estimate of $115.55 million.
Emulex Corp. sees Q2 2012 EPS of $0.17-$0.20, versus the consensus of $0.16. Emulex Corp. sees Q2 2012 revenue of $121-$127 million, versus the consensus of $122 million.
Emulex Corp. sees Q2 2012 EPS of $0.17-$0.20, versus the consensus of $0.16. Emulex Corp. sees Q2 2012 revenue of $121-$127 million, versus the consensus of $122 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- MapLight Therapeutics, Inc. (MPLT) Misses Q2 EPS by 33c
- Eikon Therapeutics, Inc. (EIKN) Misses Q2 EPS by 163c
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
